Sirolimus for the Treatment of Juvenile Polyposis in Childhood.
No Thumbnail Available
Identifiers
Date
2021-08-25
Authors
Martín-Masot, Rafael
Cardelo Autero, Nerea
Ortiz Pérez, Pilar
Torcuato Rubio, Encarnación
Vázquez Pedreño, Luis
Gallego Fernández, Carmen
Blasco-Alonso, Javier
Navas-López, Víctor Manuel
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Juvenile polyposis syndrome (JPS) is a rare disease with an autosomal dominant inheritance pattern characterized by the development of multiple hamartomatous polyps in the gastrointestinal tract. The most frequent signs and symptoms are recurrent abdominal pain, rectal bleeding, anemia, and iron deficiency. The treatment of JPS is symptomatic, requiring serial endoscopic polypectomies or intestinal resections in the most severe cases. We describe the clinical case of a patient with JPS with a childhood juvenile polyposis phenotype because of a mutation on the SMAD4 gene, who received treatment with sirolimus successfully.